So far, only a few transcription factors have been characterized to promote EIF4EBP1 transcription in other tumor entities, including the androgen receptor in prostate cancer [36], ETS1 and MYBL2 in glioblastoma [37], and MYCN in neuroblastoma [29]. The gene discussed is MYCN; the disease is neuroblastoma.